Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial
具有高循环细胞毒性 T 细胞和肿瘤内免疫特征的肝细胞癌患者可从派姆单抗中获益:单臂 2 期试验结果
期刊:Genome Medicine
影响因子:10.4
doi:10.1186/s13073-021-00995-8
Jung Yong Hong #, Hee Jin Cho #, Jason K Sa #, Xiaoqiao Liu #, Sang Yun Ha #, Taehyang Lee, Hajung Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hee Chul Park, Tae Wook Kang, Hyunchul Rhim, Su Jin Lee, Razvan Cristescu, Jeeyun Le